__
Proteonomix, Inc. (PROT) Plans European Investor Road Show
-Michael Cohen, Chairman and CEO, to Visit Several European Cities to Discuss Company’s Growth Plan and Future Outlook With Investors
PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced last week that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.
Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.
The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company.
For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.
“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD).
__
General Electric Co. (NYSE: GE)
Affinity Medical Chooses Stimulus Simplicity, GE
Northeast Wisconsin’s nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley’s Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.
“We couldn’t be more pleased with the flexible offering we’ll get from GE,” said Dr. Peter Roloff, Affinity’s Director of Medical Informatics and physician sponsor for the implementation. “Because we opted for a hosted offering, our 220 doctors will rely upon the security and stability of GE’s Tier 1 data center.
After weighing it against several competitive offerings, we’re confident GE’s solution, combined with the attractive financing terms of its Stimulus Simplicity program, is the right fit for our network today. As for tomorrow, the scalability of the hosted offering will allow GE to grow along with us, no matter how our future takes shape.”
Affinity will benefit from GE’s Stimulus Simplicity™ financing program which combines flexible financing terms* from GE Capital with a software certification warranty from GE Healthcare**. Affinity will take advantage of GE Capital’s 0% interest financing with deferred payments until 2012 to align with expected reimbursement timeframes* under the American Recovery and Reinvestment Act (ARRA) of 2009.
The GE Healthcare software certification warranty addresses a key barrier to initial investment in EHR technology by removing much of the risk around the recently defined meaningful use guidelines and associated product certification criteria. By pledging to seek achievement of ARRA-focused certification for its eligible products within the Centricity EMR, Centricity Enterprise and Centricity Business suites, GE Healthcare is standing by its customers through a time of uncertainty. Use of a certified EMR is one of the precursors to eligibility for ARRA meaningful use incentives.
“For forty years, GE has been partnering with some of the leaders in the utilization of information technology to drive patient care,” said Jim Corrigan, vice president and general manager of GE Healthcare IT. “Affinity is routinely recognized for its forward-thinking approach, including its recent achievement of ‘Excellent,’ the highest possible ranking from the National Committee for Quality Assurance. We’re anxious to explore the boundary-less potential of our new relationship with Affinity.”
General Electric Company (GE) operates as a technology, media, and financial services company worldwide. Its Energy Infrastructure segment produces gas, steam, and aero derivative turbines; generators; combined cycle systems; and renewable energy solutions, as well as provides water treatment services and equipment. This segment also sells surface and subsea drilling and production systems, floating production platform equipment, compressors, turbines, turboexpanders, and high pressure reactors to oil and gas companies, as well as provides related services.
__

MetLife, Inc. (NYSE: MET)
MetLife Finds Employee Health is a Global Issue Among Employers
Underscoring the universality of employee health issues, global companies that take an active approach to employee health and well-being can see a positive impact on their bottom line, according to a new white paper released today from MetLife.
MetLife Multinational Solutions and the MetLife Mature Market Institute, in coordination with the Sloan Center on Aging & Work at Boston College, undertook detailed examinations at four large multinational companies to determine chronic diseases, lifestyle-related health issues, and other trends impacting employees’ health, the impact on costs and productivity, and how these issues are being addressed.
“While there are different issues at play in different cultures – needing tailored solutions – the universal truth is that investing in employee health is important for long-term business success. The MetLife study provides insights into how multinational employers can overcome challenges to encourage a workplace culture of health while maintaining a competitive business model,” said Rudy Bethea, vice president, Multinational Solutions, MetLife.
The MetLife study highlights practices of four leading, multinational corporations, American Express, CEMEX, GlaxoSmithKline and PPG Industries, focusing on their wellness programs at sites in India, Mexico, China, the Philippines, the U.S. and the U.K. As these employers face challenges and opportunities that vary across the globe, such as local culture, local government, employee acceptance, availability of health care vendors and communication with employees, the study looks at the specific steps taken to maximize employee health globally to reach solutions that fit business and employee needs.
“General access to affordable health care, the prevalence of chronic disease and a growing aging labor force are all factors that today’s multinational employers must consider as they develop policies, physical facilities and behavioral standards within the workplace that are supportive of healthy living,” adds Bethea. “We believe employers can learn from the successes of the four companies featured in the MetLife resource as they navigate the ever-changing global health environment and design cost effective health and wellness programs that address the needs of their employees and their business.”
Connecting Global and Local Health – Key Themes from the Study
Key trends uncovered by the study highlight how today’s global employers are managing their workforce’s health, including:
An increased focus on creating a culture of health rather than isolated programs
While the concept of employee wellness is not new, employers are now focused on creating an overall culture of health. To help address issues facing their employees such as chronic disease and lifestyle related health issues, employers have taken a more holistic approach to wellness and are developing policies, physical facilities and behavioral standards within the workplace that are supportive of healthy living.
Health trends are changing all over the world
Chronic disease and lifestyle related health issues are increasing, not only in developed countries like the U.S. and the U.K., but also in emerging economies such as Mexico, China, and India, where a middle class is starting to thrive. In China and the Philippines, access to consistent health care by the overall population is a problem. Employers with global operations are trying to navigate and address these issues which have a significant impact on the health of the workforce base.
Local health care costs drive employer focus
In the U.S., a major goal of employers is to reduce long-term health care costs, in addition to reducing employee absenteeism, increasing productivity, improving engagement and retention, and being an employer of choice. Outside the U.S., however, medical costs are lower, so employers can concentrate on the latter four objectives.
Best Practices for Global Companies
Bethea highlights the following best practices followed by the participating multinational corporations as considerations for employers when implementing a successful global health and wellness program:
- Consider the Business Drivers. Think about the factors that drive an organization’s interest prior to implementing a health and wellness program. When launching a global strategy, keep in mind that business drivers are likely to vary depending on cultural and political influences. Also consider developing a program that serves as an extension of the company’s brand, mission or philosophy.
- Evaluate Progress. In addition to identifying business drivers to influence, outline the outcomes the company hopes to achieve. Know the health-related indicators that give the overall profile of a facility to help embed health and wellness in the culture of the organization, and track program participation from the onset. One measurement tactic might be to embed health questions that examine markers of well-being in the company’s annual survey to measure success.
- Balance Corporate Goals with Government Mandates and Cultural Expectations. Once a company has identified its overarching goals at the corporate level and in each country, it can be helpful to engage local partners as part of the implementation plan. Finding a balance between standardized processes and branding with some elements that are customized locally can be key to success, and engaging local employees in different regions may encourage greater participation. Be open to various methods of implementation depending on a location’s culture.
By incorporating these best practices during the planning and implementation stage of any health and well-being program, employers will have in place a framework to build a global program that is locally flexible and maximizes its benefits to both employers and employees.
About MetLife
MetLife is a subsidiary of MetLife, Inc.(NYSE: MET), a leading provider of insurance and financial services with operations throughout the United States and the Latin America, Europe and Asia Pacific regions. Through its domestic and international subsidiaries and affiliates, MetLife, Inc. reaches more than 70 million customers around the world and MetLife is the largest life insurer in the United States (based on life insurance in-force).
The MetLife companies offer life insurance, annuities, auto and home insurance, retail banking and other financial services to individuals, as well as group insurance, reinsurance and retirement & savings products and services to corporations and other institutions.
__
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)
____________________
Sign Up for our FREE Daily Stock Newsletter
____________________

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com









